A 4‑week postpartum woman with moderate‑to‑severe peripartum depression is prescribed sertraline and wishes to continue breastfeeding; what counseling should be provided regarding breastfeeding while on sertraline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sertraline and Breastfeeding in Peripartum Depression

Continue breastfeeding while taking sertraline and monitor the infant for adverse effects. Sertraline is one of the safest antidepressants during lactation, with minimal infant exposure and no need to discontinue nursing or discard milk 1, 2.

Evidence Supporting Continued Breastfeeding

  • Sertraline is minimally excreted in breast milk, providing the infant less than 10% of the maternal daily dose (normalized for weight), with most studies showing undetectable or very low infant plasma concentrations 1, 3.

  • Paroxetine and sertraline are considered first-line agents for breastfeeding mothers with depression, as they produce the lowest infant plasma levels among SSRIs 4.

  • Recent pharmacokinetic data confirm safety: In a 2024 study of 37 lactating women, sertraline was undetectable in all 15 infant plasma samples despite being present in all breastmilk samples, demonstrating that breastmilk transfer does not translate to clinically significant infant drug exposure 3.

Practical Counseling Points

What to Tell the Patient

  • Breastfeeding should continue without interruption or pumping and discarding milk 1, 2.

  • Start with low doses and titrate slowly to the lowest effective dose while carefully monitoring the newborn 2.

  • Monitor the infant for specific adverse effects including irritability, poor feeding, uneasy sleep, increased sleepiness, or decreased alertness—particularly if the infant was born premature or had low birth weight 1, 2.

Timing Considerations (Optional)

  • When feasible, infant exposure can be minimized by avoiding breastfeeding at times when milk antidepressant concentration is at its peak, though this is not necessary for safety 2.

Why Other Options Are Incorrect

Discontinuing Breastfeeding Is Not Recommended

  • The benefits of breastfeeding outweigh minimal drug exposure risks 1, 2, 3.

  • Discontinuation creates additional risks including breast engorgement, mastitis requiring antibiotics, infant refusal of bottle feeding, and reactions to cow's milk protein 1.

Pumping and Discarding Is Unnecessary

  • No waiting period or milk discarding is required with sertraline at therapeutic doses 1, 2.

  • This practice is illogical given that women are encouraged to breastfeed immediately after cesarean section despite higher drug passage during the immediate postpartum period when intercellular gaps are wider 1.

Psychotherapy Alone May Be Insufficient

  • For moderate to severe peripartum depression, antidepressant medication in combination with therapy is recommended 5.

  • Psychotherapy is first-line only for mild to moderate depression, not the moderate to severe symptoms described in this case 5.

Important Caveats

  • Individual risk-benefit assessment should always be performed, but the evidence strongly supports continuing both sertraline and breastfeeding 4.

  • If the mother was already taking sertraline during pregnancy, she should definitely continue while breastfeeding, as switching medications introduces unnecessary risks 2, 4.

  • The risks of untreated maternal depression must be weighed against the minimal risks of infant drug exposure through breastmilk 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antidepressant Use During Breastfeeding.

Current women's health reviews, 2011

Research

Management of postpartum depression.

Journal of midwifery & women's health, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.